Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?

Unicycive Therapeutics Ownership Summary

Unicycive Therapeutics is owned by 3.18% institutional investors, 5.22% insiders, and 91.60% retail investors. Vivo capital is the largest institutional shareholder, holding 11.21% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.63% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Unicycive Therapeutics	3.18%	5.22%	91.60%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vivo capital	9.97M	11.21%	$7.92M
Logos global management lp	5.08M	5.71%	$4.03M
Walleye capital	5.00M	5.62%	$3.97M
Silverarc capital management	2.49M	2.80%	$1.97M
Acuta capital partners	2.30M	2.59%	$1.83M
Alyeska investment group	1.75M	1.97%	$1.39M
Great point partners	10.98M	1.64%	$6.31M
Nantahala capital management	9.39M	1.40%	$5.40M
Vanguard group	1.14M	1.28%	$903.75K
Geode capital management	524.49K	0.59%	$416.55K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Great point partners	10.98M	3.34%	$6.31M
Octagon capital advisors lp	904.00K	2.15%	$11.11M
Acuta capital partners	2.30M	1.84%	$1.83M
Vivo capital	9.97M	0.89%	$7.92M
Logos global management lp	5.08M	0.47%	$4.03M
Silverarc capital management	2.49M	0.43%	$1.97M
Nantahala capital management	9.39M	0.21%	$5.40M
Xtx topco	171.46K	0.01%	$136.18K
Walleye capital	5.00M	0.01%	$3.97M
Tandem capital management corp /adv	15.50K	0.01%	$12.31K

Top Buyers

Holder	Shares	% Assets	Change
Vivo capital	9.97M	0.89%	5.50M
Acuta capital partners	2.30M	1.84%	323.80K
Geode capital management	524.49K	-	122.09K
Xtx topco	171.46K	0.01%	100.68K
State street	125.24K	-	81.30K

Top Sellers

Holder	Shares	% Assets	Change
Octagon capital advisors lp	904.00K	2.15%	-9.10M
Ra capital management	-	-	-2.63M
Bvf inc/il	-	-	-2.20M
Rosalind advisors	-	-	-1.57M
Silverarc capital management	2.49M	0.43%	-1.51M

New Positions

Holder	Shares	% Assets	Change	Value
Blackrock	51.84K	-	51.84K	$25.98K
Hrt financial lp	22.13K	0.00%	22.13K	$17.00K
Bank of america corp /de/	223.00	-	223.00	$112.00
Bogart wealth	60.00	-	60.00	$48.00

Sold Out

Holder	Change
Wells fargo & company/mn	-196.00
Citigroup	-587.00
Soa wealth advisors, llc.	-1.00K
Redwood wealth management group	-3.00K
Integrated wealth concepts	-10.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	4	-87.10%	21,301,904	-65.48%	3	0.07%	1	-95.24%	2	-60.00%
Dec 31, 2024	30	7.14%	61,690,744	31.86%	69	2.51%	20	-9.09%	5	-
Sep 30, 2024	28	16.67%	46,786,564	146.28%	52	1.78%	22	100.00%	-	-100.00%
Jun 30, 2024	24	4.35%	18,997,260	-10.59%	54	0.73%	11	-26.67%	7	250.00%
Mar 31, 2024	23	43.75%	21,247,089	63.05%	86	5.43%	15	114.29%	2	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	765.00K	0.63%	-
Vanguard Institutional Extnd Mkt Idx Tr	604.71K	0.50%	157.26K
Fidelity Extended Market Index	281.66K	0.24%	-256.00
Fidelity Total Market Index	109.03K	0.09%	37.75K
iShares Micro-Cap ETF	69.73K	0.06%	-
Fidelity Series Total Market Index	68.80K	0.06%	6.36K
Spartan Extended Market Index Pool E	58.30K	0.05%	2.46K
Spartan Extended Market Index Pool F	58.30K	0.05%	2.46K
Northern Trust Extended Eq Market Idx	56.58K	0.05%	-
NT Ext Equity Mkt Idx Fd - L	56.58K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2022	Schiller Brigitte		Buy	$12.38K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2023 Q3	-	-

UNCY Ownership FAQ

Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 3.18%, followed by 5.22% insiders and 91.60% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 63.96%, which Unicycive Therapeutics falls below.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Vivo capital (9.97M shares, 11.21%), Logos global management lp (5.08M shares, 5.71%), and Walleye capital (5M shares, 5.62%). Together, they hold 22.54% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Unicycive Therapeutics.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Great point partners is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.34% of its assets in 10.98M Unicycive Therapeutics shares, valued at 6.31M$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 0.63% of its total shares outstanding invested in 765K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools